Integrin αVβ6: Autoantigen and Driver of Epithelial Remodeling in Colon and Bile Ducts in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease - Top-Institutions - MDSpire

Integrin αVβ6: Autoantigen and Driver of Epithelial Remodeling in Colon and Bile Ducts in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease

  • By

  • Dominik Roth

  • Miriam M Düll

  • Ludwig J Horst

  • Aylin Lindemann

  • Xenia Malzer

  • Kristina Koop

  • Sebastian Zundler

  • Marcel Vetter

  • André Jefremow

  • Raja Atreya

  • Carol Geppert

  • Sören Weidemann

  • Maximilian J Waldner

  • Peter Dietrich

  • Claudia Günther

  • Luis E Munoz

  • Martin Herrmann

  • Alexander Scheffold

  • Markus F Neurath

  • Jürgen Siebler

  • Christoph Schramm

  • Andreas E Kremer

  • Moritz Leppkes

  • August 30, 2024

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Gastroenterology
    • Hepatology
    • Immunology

  • #2

    Mount Sinai Health System
    Mount Sinai Health System

    New York, NY

    Key Differentiators

    • Gastroenterology
    • Hepatology
    • Autoimmune Diseases

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Gastroenterology
    • Hepatology
    • Immunology

  • #4

    Charité – Universitätsmedizin Berlin
    Charité – Universitätsmedizin Berlin

    Berlin, Berlin

    Key Differentiators

    • Gastroenterology
    • Hepatology
    • Immunology

Original Source(s)

Integrin αVβ6: Autoantigen and Driver of Epithelial Remodeling in Colon and Bile Ducts in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease

  • by Dominik Roth, Miriam M Düll, Ludwig J Horst, Aylin Lindemann, Xenia Malzer, Kristina Koop, Sebastian Zundler, Marcel Vetter, André Jefremow, Raja Atreya, Carol Geppert, Sören Weidemann, Maximilian J Waldner, Peter Dietrich, Claudia Günther, Luis E Munoz, Martin Herrmann, Alexander Scheffold, Markus F Neurath, Jürgen Siebler, Christoph Schramm, Andreas E Kremer, Moritz Leppkes

  • August 30, 2024

Related Content

Therapeutic Approaches for Inflammatory Bowel Disease: The Role of Immunomodulators, Biologics, and 5-Aminosalicylates in Cardiovascular Risk Management

Case Report: Bilateral panuveitis with serous ciliary body and choroidal detachment associated with ulcerative colitis

Editorial: Volume II of the Community Series on Gut Microbiota and Immune Interactions in Intestinal Disorders